feeling sick; shaking; feeling overwhelmingly nauseous; sweating really bad; short of breath; hyperventilating; ringing in my ears; extremely dizzy; hearing cut out; full body aches / alot of pain; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  A 21-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Jan2022 13:30 (Lot number: FK9729) at the age of 21 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Major Depression" (unspecified if ongoing); "hypoglycemia" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "Known allergies: I'm lactose intolerant" (unspecified if ongoing); "Known allergies: gluten intolerant" (unspecified if ongoing). Concomitant medication(s) included: PROZAC; SINGULAIR; VITAMIN D3; VYVANSE. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0173, Location of injection: Arm Left), administration date: 08May2021, when the patient was 20 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0158, Location of injection: Arm Left), administration date: 17Apr2021, when the patient was 20 years old, for COVID-19 Immunization. No other vaccine in four weeks. No COVID prior vaccination; not COVID tested post vaccination. The following information was reported: DEAFNESS (medically significant) with onset 24Jan2022 06:00, outcome "recovering", described as "hearing cut out"; PAIN (non-serious) with onset 23Jan2022 21:00, outcome "recovering", described as "full body aches / alot of pain"; MALAISE (non-serious) with onset 24Jan2022 06:00, outcome "recovering", described as "feeling sick"; TREMOR (non-serious) with onset 24Jan2022 06:00, outcome "recovering", described as "shaking"; NAUSEA (non-serious) with onset 24Jan2022 06:00, outcome "recovering", described as "feeling overwhelmingly nauseous"; HYPERHIDROSIS (non-serious) with onset 24Jan2022 06:00, outcome "recovering", described as "sweating really bad"; DYSPNOEA (non-serious) with onset 24Jan2022 06:00, outcome "recovering", described as "short of breath"; HYPERVENTILATION (non-serious) with onset 24Jan2022 06:00, outcome "recovering", described as "hyperventilating"; TINNITUS (non-serious) with onset 24Jan2022 06:00, outcome "recovering", described as "ringing in my ears"; DIZZINESS (non-serious) with onset 24Jan2022 06:00, outcome "recovering", described as "extremely dizzy". Therapeutic measures were not taken as a result of deafness, malaise, tremor, nausea, hyperhidrosis, dyspnoea, hyperventilation, tinnitus, dizziness. Therapeutic measures were taken as a result of pain. Clinical course: On 23Jan2022 21:00 ("around 9pm"), patient started having full body aches and took ibuprofen. She went to sleep and woke up around 24Jan2022 06:00 in a lot of pain and feeling sick and shaking. When she went to the bathroom to get more ibuprofen and check her temperature (99.5 F). She started feeling overwhelmingly nauseous, shaking and sweating really bad, short of breath/hyperventilating, ringing in my ears/hearing cut out, and extremely dizzy. She had to sit on the floor, so she didn't fall over and pass out.